| Literature DB >> 27766260 |
Yuan-Jhen Syue1, Jyun-Bin Huang2, Fu-Jen Cheng2, Chia-Te Kung2, Chao-Jui Li2.
Abstract
Background. The survival rates of in-hospital cardiac arrests (IHCAs) are reportedly low at night, but the difference between the survival rates of cardiac origin and noncardiac origin IHCAs occurring at night remains unclear. Methods. Outcomes of IHCAs during different shifts (night, day, and evening) were compared and stratified according to the etiology (cardiac and noncardiac origin). Result. The rate of return of spontaneous circulation (ROSC) was 24.7% lower for cardiac origin IHCA and 19.4% lower for noncardiac origin IHCA in the night shift than in the other shifts. The survival rate was 8.4% lower for cardiac origin IHCA occurring during the night shift, but there was no difference for noncardiac origin IHCA. After adjusting the potential confounders, chances of ROSC (aOR: 0.3, CI: 0.15-0.63) and survival to discharge (aOR: 0.1; CI: 0.01-0.90) related to cardiac origin IHCA were lower during night shifts. Regarding noncardiac origin IHCA, chances of ROSC (aOR: 0.5, CI: 0.30-0.78) were lower in the night shift, but chances of survival to discharge (aOR: 1.3, CI: 0.43-3.69) were similar in these two groups. Conclusion. IHCA occurring at night increases mortality, and this is more apparent for cardiac origin IHCAs than for noncardiac origin IHCA.Entities:
Mesh:
Year: 2016 PMID: 27766260 PMCID: PMC5059516 DOI: 10.1155/2016/4626027
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Patient demographics.
| Day/evening (331) | Night (213) |
| |||
|---|---|---|---|---|---|
|
| 67.1 | ±15.17 | 68.1 | ±14.84 | 0.428 |
|
| 196 | 59.2% | 124 | 58.2% | 0.817 |
|
| 4.5 | ±2.57 | 4.8 | ±2.53 | 0.201 |
|
| |||||
| Coronary artery disease | 49 | 14.8% | 30 | 14.1% | 0.816 |
| Congestive heart failure | 53 | 16.0% | 29 | 13.6% | 0.446 |
| Cerebral vascular disease | 76 | 23.0% | 52 | 24.4% | 0.697 |
| Chronic pulmonary disease | 72 | 21.8% | 48 | 22.5% | 0.830 |
| Chronic liver disease | 72 | 21.8% | 62 | 29.1% | 0.052 |
| Chronic kidney disease | 127 | 38.4% | 76 | 35.7% | 0.527 |
| DM | 129 | 39.0% | 79 | 37.1% | 0.659 |
| Malignancy | 104 | 31.4% | 67 | 31.5% | 0.993 |
| Hematologic disease | 20 | 6.0% | 12 | 5.6% | 0.843 |
| Psychiatric disorder | 10 | 3.0% | 3 | 1.4% | 0.229 |
|
| |||||
| Cardiovascular disease | 32 | 9.7% | 14 | 6.6% | 0.205 |
| Cerebral vascular disease | 13 | 3.9% | 13 | 6.1% | 0.246 |
| Infection | 106 | 32.0% | 81 | 38.0% | 0.150 |
| Complication of liver cirrhosis | 21 | 6.3% | 23 | 10.8% | 0.063 |
| Complication of renal failure | 22 | 6.6% | 12 | 5.6% | 0.634 |
| Complication of DM | 10 | 3.0% | 2 | 0.9% | 0.107 |
| Malignancy | 67 | 20.2% | 36 | 16.9% | 0.332 |
| Hematologic disease | 15 | 4.5% | 4 | 1.9% | 0.100 |
Event characteristics.
| Day/evening (331) | Night (213) |
| |||
|---|---|---|---|---|---|
|
| |||||
| Internal medicine | 297 | 89.7% | 193 | 90.6% | 0.469 |
| Surgical medicine | 24 | 7.3% | 17 | 8.0% | |
| Other | 10 | 3.0% | 3 | 1.4% | |
|
| |||||
| Oxygen therapy | 163 | 49.2% | 115 | 54.0% | 0.280 |
| Inhalation therapy | 29 | 8.8% | 28 | 13.1% | 0.103 |
| Vascular access | 306 | 92.4% | 201 | 94.4% | 0.386 |
| Antibiotics therapy | 199 | 60.1% | 128 | 60.1% | 0.995 |
| Inotropic agent | 7 | 2.1% | 2 | 0.9% | 0.294 |
|
| |||||
| Vf or pulseless VT | 19 | 5.70% | 2 | 0.90% | <0.001 |
| PEA | 222 | 67.10% | 114 | 53.50% | |
| Asystole | 90 | 27.20% | 97 | 45.50% | |
|
| |||||
| Deteriorated disease course | 189 | 57.1% | 108 | 50.7% | 0.144 |
| Witnessed | 256 | 77.3% | 98 | 46.0% | <0.001 |
| Bystander CPR | 135 | 40.8% | 50 | 23.5% | <0.001 |
|
| |||||
| Cardiac origin | 115 | 34.7% | 85 | 39.9% | 0.223 |
| Noncardiac origin | 216 | 65.3% | 128 | 60.1% | |
Figure 1Percentage of witnessed event and bystander CPR at the time of the event per shift: (a) cardiac origin in-hospital cardiac arrest and (b) noncardiac origin in-hospital cardiac arrest.
Figure 2Percentage of initial rhythm at the time of the event per shift: (a) cardiac origin in-hospital cardiac arrest and (b) noncardiac origin in-hospital cardiac arrest. VF: ventricular fibrillation; VT: ventricular tachycardia; PEA: pulseless electrical activity.
Figure 3Percentage of ROSC and survival to discharge of the event per shift: (a) cardiac origin in-hospital cardiac arrest and (b) noncardiac origin in-hospital cardiac arrest.
Cardiac arrest outcomes by day/evening versus night.
| Outcome | Day or evening shift | Night shift | |
|---|---|---|---|
| Reference | aOR | 95% CI | |
|
| |||
| ROSC | [ | 0.3 | 0.15~0.63 |
| Survival to discharge | [ | 0.1 | 0.01~0.90 |
|
| |||
| ROSC | [ | 0.5 | 0.30~0.78 |
| Survival to discharge | [ | 1.3 | 0.43~3.69 |
Significant factor.
ROSC: return of spontaneous circulation.
aOR: adjusted odds ratio, for patient's age, sex, CCI, first documented cardiac rhythm, witnessed cardiac arrest, and bystander CPR.
Figure 4The distribution of patients with survival to discharge in the Cerebral Performance Category score: 1 for good cerebral performance, 2 for moderate performance, 3 for poor performance, and 4 for comatose or vegetative status.